70 A 20-Year Outcomes' Study of Patients With Immunoglobulin G4-Related Sclerosing Cholangitis: The Mayo Clinic Experience

AH Ali, Y Bi, J Machicado, S Garg… - Official journal of the …, 2019 - journals.lww.com
METHODS: In this retrospective, single center, cohort study, we identified patients who
received a diagnosis of IgG4-SC at Mayo Clinic Rochester from 1999 to 2018. The diagnosis …

Different manifestations of IgG4 related sclerosing cholangitis: Clinical myths and pearls.

A Hormati, A Faraji, B Behnam… - Iranian Journal of …, 2021 - search.ebscohost.com
Introduction: IgG4-related sclerosing cholangitis is a rare inflammatory disease that
characterized by elevated serum IgG4 levels, storiform fibrosis pattern of IgG4 positive …

Elevated serum and tissue levels of IgG4 in Primary Sclerosing Cholangitis are associated with a worse clinical outcome: 2024

EL Culver, KD Williamson, J Halliday, R Sadler… - Hepatology, 2012 - journals.lww.com
Introduction-IgG4-related cholangitis (IC) is the biliary manifestation of IgG4-related disease,
an increasingly recognised phenomenon with elevated serum and tissue IgG4 incorporated …

Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification

T Nakazawa, I Naitoh, K Hayashi, F Okumura… - Journal of …, 2012 - Springer
Background IgG4-related sclerosing cholangitis (IgG4-SC) needs to be differentiated from
pancreatic cancer (PCa), primary sclerosing cholangitis (PSC), and cholangiocarcinoma …

[PDF][PDF] Clinical features of isolated proximal‐type immunoglobulin G4‐related sclerosing cholangitis

髙木由理, タカギユリ - ycu.repo.nii.ac.jp
IgG4 関連硬化性胆管炎 (IgG4-SC) は, ステロイド反応性の良性疾患で, 診断には IgG4
関連硬化性胆管炎臨床診断基準 (岡崎ら, 2012) が用いられ, 胆管像や病理所見から診断がなされ …

[引用][C] IgG4 相关硬化性胆管炎临床特点分析

宋静静, 王冬梅, 杜晓菲, 柳雅立, 张晶, 仇丽霞 - 北京医学, 2021

A case report of immunoglobulin G4-related sclerosing cholangitis with multiple relapse

X Dong, N Huo, Z Wu, G Wang, H Wang, H Zhao - Medicine, 2018 - journals.lww.com
Interventions: Prednisolone was started from 40 mg daily, tapered gradually, and totally
withdrawn after 22 months of treatment. Outcomes: A new-onset cholangitis was detected 2 …

Nationwide survey for primary sclerosing cholangitis and IgG 4‐related sclerosing cholangitis in J apan

A Tanaka, S Tazuma, K Okazaki… - Journal of Hepato …, 2014 - Wiley Online Library
Background We previously conducted nationwide surveys for primary sclerosing cholangitis
(PSC) in J apan, and demonstrated several characteristic features of J apanese PSC …

A6 HIGH SERUM IGG4 IS ASSOCIATED WITH A SHORTER TIME TO CIRRHOSIS DEVELOPMENT, HEPATIC DECOMPENSATION, AND LIVER …

L Du, AJ Montano-Loza, F Peerani - Journal of the Canadian …, 2018 - academic.oup.com
Background Primary sclerosing cholangitis (PSC) is an immune-mediated biliary disorder of
unknown etiology for which there is no effective treatment. Eventually all PSC patients …

Diagnostic Criteria

H Ohara, I Naitoh, K Hayashi, K Miyabe… - IgG4-Related Sclerosing …, 2019 - Springer
As IgG4-related sclerosing cholangitis (IgG4-SC) exhibits various cholangiographic features
similar to those of primary sclerosing cholangitis (PSC), pancreatic cancer, and …